Financhill
Back

Inozyme Pharma Stock Predictions

Inozyme Pharma Stock Forecast

  • Is Inozyme Pharma Stock Undervalued?
    The current Inozyme Pharma [INZY] share price is $3.03. The Score for INZY is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • INZY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Inozyme Pharma Stock Go Up Next Year?

Data Unavailable

Inozyme Pharma Stock Rating

Data Unavailable

Inozyme Pharma Stock Price History

Is INZY stock going to rise?

  • The current trend is relatively stagnant and INZY is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
inozyme.com

52-Week Data

52-Week High:
7.80
52-Week Low:
2.39

Prediction Charts

Market Cap:
194.65M
Price in USD:
3.03
Volume:
809.56K
Beta:
1.38

Technical Analysis

SMA50:
3.93
SMA100:
4.57
SMA200:
4.86
52-Wk Change:
-24.63%

Stock Predictions

  • Is Inozyme Pharma stock public?
    Yes, Inozyme Pharma is a publicly traded company.
  • What is the Inozyme Pharma stock quote today?
    The Inozyme Pharma stock price is 3.03 USD today.
  • How to buy Inozyme Pharma stock online?
    You can buy Inozyme Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-25 2.84 2.64 2.89 2.62
Nov-26 2.65 2.65 2.78 2.56
Nov-27 2.69 2.72 2.74 2.58
Nov-29 2.76 2.71 2.80 2.68
Dec-2 2.75 2.79 2.85 2.55
Dec-3 2.81 2.62 2.85 2.57
Dec-4 2.60 2.69 2.73 2.59
Dec-5 2.66 2.48 2.69 2.48
Dec-6 2.52 2.57 2.62 2.39
Dec-9 2.60 2.72 2.81 2.58
Dec-10 2.78 2.98 3.05 2.75
Dec-11 2.98 2.96 3.04 2.75
Dec-12 3.14 2.98 3.46 2.95
Dec-13 2.98 3.03 3.10 2.81

Inozyme Pharma Earnings

Data Unavailable

Inozyme Pharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.03 per share.

* Inozyme Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.